Synergism between ATM and PARP1 Inhibition Involves DNA Damage and Abrogating the G2 DNA Damage Checkpoint

JPY Mak, HT Ma, RYC Poon - Molecular cancer therapeutics, 2020 - AACR
DNA ligase III activation and the alignment of DNA ends … in tumors deficient in homologous
recombination repair (HRR) … B–CDK1. ATM itself appears to contribute a minor role to the …

CDK-mediated Yku80 phosphorylation regulates the balance between non-homologous end joining (NHEJ) and homologous directed recombination (HDR)

R Carballar, JM Martínez-Láinez, B Samper… - Journal of Molecular …, 2020 - Elsevier
… -prone non-homologous end joining (NHEJ) pathways … DNA ends permitting the following:
First, telomere capping which is essential for the inhibition of the telomere 5′-end resection,…

The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment

S Li, L Wang, Y Wang, C Zhang, Z Hong… - Journal of Hematology & …, 2022 - Springer
… mainly by high-fidelity homologous recombination (HR) or … at DSB sites and facilitating
DNA end resection, in which its … The inactivation of the CDC family causes CDK2 and CDK1

Cyclin-dependent kinase inhibitors (CDKIs) and the DNA damage response: the link between signaling pathways and cancer

J Amani, N Gorjizadeh, S Younesi, M Najafi, AM Ashrafi… - DNA repair, 2021 - Elsevier
… Taken together, inhibition of CDK1 causes activation of the DNA damage … a G1 DNA damage
checkpoint, but it also participates directly in the DDR pathway downstream of activation of …

New insights into the regulation of DNA end processing and DNA damage checkpoint

C Colombo - 2019 - boa.unimib.it
… Both DNA end resection and DNA damage checkpoint have … mechanisms to repair DSBs:
Non Homologous End Joining (… most important residue for Cdk1 phosphorylation is Serine 267…

Targeting the DNA damage response for cancer therapy

NJ Curtin - Biochemical Society Transactions, 2023 - portlandpress.com
… with defects in homologous recombination DNA repair (HRR) (… , DNA-PKcs, modest end
resection, limited by 53BP1, and … M cyclin dependent kinases CDK2 and CDK1 causing S-phase …

The developing landscape of combinatorial therapies of immune checkpoint blockade with DNA damage repair inhibitors for the treatment of breast and ovarian …

L Zhu, J Liu, J Chen, Q Zhou - Journal of hematology & oncology, 2021 - Springer
… Despite the weaker impact of homologous recombination (HR) deficiency on TMB relative
to MMRd, catastrophic DNA damage driven by DDRi can be favorable to enhance ICB therapy …

[HTML][HTML] Impaired 53BP1/RIF1 DSB mediated end-protection stimulates CtIP-dependent end resection and switches the repair to PARP1-dependent end joining in G1

A Bakr, S Köcher, J Volquardsen, C Petersen… - Oncotarget, 2016 - ncbi.nlm.nih.gov
… to eliminate DSBs from the genome: non-homologous end joining (NHEJ) and homologous
… As cells enter S/G2 phase, end resection is activated via CDK1/2 mediated CtIP …

Targeting DNA repair in cancer: current state and novel approaches

A Klinakis, D Karagiannis, T Rampias - Cellular and Molecular Life …, 2020 - Springer
… the non-homologous end-joining (NHEJ) DSB repair pathway (… as a DNA sensor protein
has the ability to bind DNA ends, … dephosphorylation of CDK1–cyclin B, which is required for …

[HTML][HTML] … exhibit a strong synergistic anticancer effect on chronic myeloid leukemia cell line K562 by impairing homologous recombination DNA damage repair

Z Fan, H Luo, J Zhou, F Wang, W Zhang… - Oncology …, 2020 - spandidos-publications.com
CDK1, and shRNA-mediated CHK1 knockdown suppressed the induction of pS216 CDC25c
and pY15 CDK1 by … forces cells to enter mitosis with unrepaired DNA damage. HR and non-…